VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 1353 · 114th Congress

PATIENT Act of 2015

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

4 cosponsors · 2 D, 2 R

3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Promoting Access for Treatments Ideal in Enhancing New Therapies Act of 2015 or the PATIENT Act of 2015

What it does: CRS summary · Introduced in House · Mar 13, 2015

Promoting Access for Treatments Ideal in Enhancing New Therapies Act of 2015 or the PATIENT Act of 2015

This bill amends the Federal Food, Drug, and Cosmetic Act to extend to five years the three-year marketing exclusivity period provided to certain new drugs that include an active ingredient that was already approved by the Food and Drug Administration.

A drug is provided this extended exclusivity period if it is approved for a new indication or use, or the drug has been reformulated or redesigned to:

  • promote greater patient adherence to an approved treatment regime,
  • reduce the public health risks associated with the drug,
  • reduce side effects or adverse events,
  • provide benefits to the health-care system, or
  • provide other comparable patient benefits.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: PATIENT Act of 2015

Also known as: Promoting Access for Treatments Ideal in Enhancing New Therapies Act of 2015

Latest action (Mar 20, 2015): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: Mar 13, 2015

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.